🇩🇪Germany
Eingeschränkte Handelsmargen im Großhandel
2 verified sources
Definition
Fixed low margins in regulated drug wholesale lead to systematic revenue leakage on every order.
Key Findings
- Financial Impact: Max €38.53 wholesale mark-up per pack; 3.15% on ex-factory price[3][4]
- Frequency: Per pack sold
- Root Cause: AMPreisV mandatory price caps
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Wholesale Drugs and Sundries.
Affected Stakeholders
Pricing Analysts, Sales Directors, Finance Controllers
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
Versorgungspflichtverstöße und Lagerkosten (AMG § 52b)
€37.80 cap on mark-ups contributing to overhead; 6-month stockpiling mandates; fines for non-delivery[1][3]
Pflichtabzüge und Preisregulierungen im Arzneimittelgroßhandel
€38.53 max mark-up per pack; 7-12% mandatory rebates on manufacturer prices; €3.7 billion total pharma expenditure cuts[2][3][5]
Überlast durch manuelle Dokumentation und Mapping
20-40 hours/month manual labor at €50/hour = €1,000-2,000/month per site
Rückforderungen durch Preisfehler in Großhandelsverträgen
2-5% revenue leakage per annum
Verzögerte Zahlungen durch Chargeback-Streitigkeiten
15-30 additional Days Sales Outstanding (DSO)
Betrug durch manipulierte Rückforderungen
1-3% revenue from fraudulent chargebacks